A researcher demonstrates the procedure
Researchers in the US have demonstrated for the first time that drugs can be successfully delivered to the eye using microneedles, potentially improving the treatment of diseases such as age-related macular degeneration (AMD).
The scientists – from the Georgia Institute of Technology and Emory University – used tiny microneedles less than 1mm in length to inject drugs into the suprachoroidal space of the eye, showing in animal studies that they could travel to the rear of the eye and deliver compounds to the retina and choroid.
This is a new 4-year Structured PhD Programme in Biomedical Engineering and Regenerative Medicine, which will be delivered by a core partnership of institutions: National University of Ireland Galway (Administrative Coordinator), University of Limerick and University College Cork, linked with a wider consortium of partner institutions nationally and internationally, including: Galway-Mayo Institute of Technology, Institute of Technology Sligo, University of Ulster, Queen’s University Belfast, Georgia Institute of Technology, USA, University of Pittsburgh, USA, Duke University, USA, Rice University, USA, Mayo Clinic, USA, RWTH Aachen University, Germany, Georgia Tech Ireland, and the Irish Medical Devices Association (IMDA). BMERM combines a PhD research project with a unique didactic and experiential learning programme, resulting in an unparalleled learning experience for the student in terms of its combination of world-class research and focused clinical and industrial interaction, the latter facilitated by the direct involvement of IMDA with its membership of over 100 medical technology companies in Ireland.
This is a preview of Ph.D Positions in Biomedical Engineering & regenerative Medicine. Read the full post (501 words, 3 images, estimated 2:00 mins reading time)